Biofarm will invest 47 million lei in upgrading equipment and developing a new R&D center by 2025.
Raluca Ioana Draghici
Economy
www.shutterstock.com
Always see our news on Google
Biofarm, a leading Romanian drug manufacturer, plans to invest 47 million lei in upgrading its production plant on Logofătul Tăutu Street and developing a new research and development center. The project aims to modernize equipment in order to improve the efficiency of manufacturing processes and better respond to market demands. CEO Cătălin Vicol emphasizes that this initiative is part of Biofarm's strategy to increase its presence on international markets.
Sources
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare. Bugetul de investiţii al Biofarm în 2025 este de 47 mil. lei (aproape 10 mil. euro), în creştere faţă de anul anterior, cand a fost de 31 mil. lei
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare
Latest News
09:09
Donald Trump suggests in an interview for "Axios" a change of strategy regarding Iran: "For now, we are not forcing things"
08:53
The giant of the ice cream industry that owns Betty Ice opens a center in Bucharest with 200 employees
08:43
Interim Deputy Prime Minister Oana Gheorghiu, about the ambulance attacked in Cluj: "Ambulances do not steal children, but TikTok steals brains. We need a strong law against disinformation."
08:27
Russia claims that it has captured two villages in eastern Ukraine. Ukraine does not confirm the information.
08:14
NBA: Legendary coach Don Nelson has died at the age of 86
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
